Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

✍ Scribed by Daniel D Mikol; Frederik Barkhof; Peter Chang; Patricia K Coyle; Douglas R Jeffery; Steven R Schwid; Bettina Stubinski; Bernard MJ Uitdehaag

• Book ID: 114409022
• Publisher: The Lancet
• Year: 2008
• Tongue: English
• Weight: 216 KB
• Volume: 7
• Category: Article
• ISSN: 1474-4465
• DOI: 10.1016/s1474-4422(08)70200-x